Ahna R. Skop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahna R. Skop has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
Sungjin Park
Laboratory of Genetics, UW-Madison, Madison, WI 53706, United States
5 shared publicationsDaniel S. Poole
Department of Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
4 shared publications- Karen Schindler
Rutgers University
4 shared publications - Ahmed Zaky Balboula
Division of Animal Sciences, University of Missouri
3 shared publications Daniela Londoño-Vásquez
Animal Sciences Research Center, University of Missouri, Columbia, USA
3 shared publicationsErkang Ai
Laboratory of Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
3 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Elsevier in Cell Genomics
- Vol. 6 (10)
Mitotic and meiotic midbody remnants: Divergent architectures with distinct clinical applications
- 14 October 2026
- Published by Elsevier in Cell Genomics
- Vol. 6 (10)
Open AccessMitotic and meiotic midbody remnants: Divergent architectures with distinct clinical applications
- Open Access
Condensates on the Move: Midbody Remnants as Large, Translation‐Competent Extracellular Vesicles
Recent work has expanded understanding of extracellular vesicle (EV) biology by identifying midbody remnants (MBRs) as large, translationally competent vesicles released during mitosis. MBRs contain ribosomes, mitochondria, translation factors, and selected mRNAs and small RNAs concentrated within a condensate‑like ribonucleoprotein core and can support protein synthesis after extracellular release. These features distinguish MBRs from more extensively studied exosomes and microvesicles yet also place them within a broader continuum of large EVs with organelle‑rich, cell‑like properties. This review summarizes current knowledge of MBR biogenesis, molecular organization, and translation competency; contrasts MBRs with canonical EVs and other large EVs; and discusses possible roles in development, tissue homeostasis, disease, and brain function. Particular emphasis is placed on outstanding mechanistic and physiological questions, including how MBR translation is regulated, which recipient cells interact with endogenous MBRs, and whether translation‑competent EVs offer practical advantages over existing EV platforms for therapeutic or biotechnological applications.
Open AccessCondensates on the Move: Midbody Remnants as Large, Translation‐Competent Extracellular Vesicles
Recent work has expanded understanding of extracellular vesicle (EV) biology by identifying midbody remnants (MBRs) as large, translationally competent vesicles released during mitosis. MBRs contain ribosomes, mitochondria, translation factors, and selected mRNAs and small RNAs concentrated within a condensate‑like ribonucleoprotein core and can support protein synthesis after extracellular release. These features distinguish MBRs from more extensively studied exosomes and microvesicles yet also place them within a broader continuum of large EVs with organelle‑rich, cell‑like properties. This review summarizes current knowledge of MBR biogenesis, molecular organization, and translation competency; contrasts MBRs with canonical EVs and other large EVs; and discusses possible roles in development, tissue homeostasis, disease, and brain function. Particular emphasis is placed on outstanding mechanistic and physiological questions, including how MBR translation is regulated, which recipient cells interact with endogenous MBRs, and whether translation‑competent EVs offer practical advantages over existing EV platforms for therapeutic or biotechnological applications.
- 1 July 2025
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 36 (7)
The midbody and midbody remnant: from cellular debris to signaling organelle with diagnostic and therapeutic potential
The midbody (MB), a transient structure formed during cytokinesis, has evolved from a mere structural component to a complex signaling organelle with diverse functions beyond cell division. Recent studies have revealed that jettisoned MB remnants (MBR) play crucial roles in intercellular communication, influencing cell fate decisions, particularly in stem cells and cancer. MBRs act as large extracellular vesicles, transferring functional RNA and proteins that modulate cell behavior, including proliferation and cancer progression. The protein KIF23, associated with MBs, is a pan-cancer marker, underscoring the clinical relevance of MB research. This review highlights the emerging significance of MBs and MBRs in cancer biology, neurobiology, and regenerative medicine, offering new avenues for diagnostic and therapeutic strategies. By reshaping our understanding of cell division and intercellular communication, these findings open exciting frontiers in cell biology with huge potential for diagnostic and therapeutic applications.
- 1 July 2025
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 36 (7)
The midbody and midbody remnant: from cellular debris to signaling organelle with diagnostic and therapeutic potential
The midbody (MB), a transient structure formed during cytokinesis, has evolved from a mere structural component to a complex signaling organelle with diverse functions beyond cell division. Recent studies have revealed that jettisoned MB remnants (MBR) play crucial roles in intercellular communication, influencing cell fate decisions, particularly in stem cells and cancer. MBRs act as large extracellular vesicles, transferring functional RNA and proteins that modulate cell behavior, including proliferation and cancer progression. The protein KIF23, associated with MBs, is a pan-cancer marker, underscoring the clinical relevance of MB research. This review highlights the emerging significance of MBs and MBRs in cancer biology, neurobiology, and regenerative medicine, offering new avenues for diagnostic and therapeutic strategies. By reshaping our understanding of cell division and intercellular communication, these findings open exciting frontiers in cell biology with huge potential for diagnostic and therapeutic applications.
- 1 December 2024
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 35 (12)
Extracellular vesicles, including large translating vesicles called midbody remnants, are released during the cell cycle
Extracellular vesicles (EVs) play crucial roles in cell-cell communication, but the biogenesis of large EVs has remained elusive. Here, we show that the biogenesis of large EVs (>800 nm–2 µm) occurs predominantly through the completion of successful cytokinesis, and the majority of large EVs are midbody remnants (MBRs) with translation activity, and the unique marker MKLP1. Blocking the cell cycle or cytokinesis, genetically or chemically, significantly decreases MBRs and large (800 nm–2 µm), medium (500–800 nm), and small (<300 nm) EVs, suggesting that proliferative cells can also generate all sizes of EVs. The canonical EV markers including CD9, CD63, CD81 localize to the spindle midzone, midbody, and MBRs, suggesting that these markers are not specific for detecting EVs exclusively. Importantly, all commonly used EV isolation methods isolate MBRs, confounding previous EV research. Last, isolated MBRs maintain translation activity regardless of the isolation method. We propose a model for the biogenesis of EVs throughout the cell cycle and suggest that some large EVs are primarily generated from mitotic cells. The discovery of MBRs as a unique class of large, translating EVs has implications for using them as cancer diagnostic markers and for engineering them for therapeutic cargo delivery during mitosis.
- 1 December 2024
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 35 (12)
Extracellular vesicles, including large translating vesicles called midbody remnants, are released during the cell cycle
Extracellular vesicles (EVs) play crucial roles in cell-cell communication, but the biogenesis of large EVs has remained elusive. Here, we show that the biogenesis of large EVs (>800 nm–2 µm) occurs predominantly through the completion of successful cytokinesis, and the majority of large EVs are midbody remnants (MBRs) with translation activity, and the unique marker MKLP1. Blocking the cell cycle or cytokinesis, genetically or chemically, significantly decreases MBRs and large (800 nm–2 µm), medium (500–800 nm), and small (<300 nm) EVs, suggesting that proliferative cells can also generate all sizes of EVs. The canonical EV markers including CD9, CD63, CD81 localize to the spindle midzone, midbody, and MBRs, suggesting that these markers are not specific for detecting EVs exclusively. Importantly, all commonly used EV isolation methods isolate MBRs, confounding previous EV research. Last, isolated MBRs maintain translation activity regardless of the isolation method. We propose a model for the biogenesis of EVs throughout the cell cycle and suggest that some large EVs are primarily generated from mitotic cells. The discovery of MBRs as a unique class of large, translating EVs has implications for using them as cancer diagnostic markers and for engineering them for therapeutic cargo delivery during mitosis.
- 21 March 2024
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- Vol. 25 (5) , 339
Localized translation in the embryo
- 21 March 2024
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- Vol. 25 (5) , 339
Localized translation in the embryo
- Open Access
- 16 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
An oocyte meiotic midbody cap is required for developmental competence in mice
Embryo development depends upon maternally derived materials. Mammalian oocytes undergo extreme asymmetric cytokinesis events, producing one large egg and two small polar bodies. During cytokinesis in somatic cells, the midbody and subsequent assembly of the midbody remnant, a signaling organelle containing RNAs, transcription factors and translation machinery, is thought to influence cellular function or fate. The role of the midbody and midbody remnant in gametes, in particular, oocytes, remains unclear. Here, we examined the formation and function of meiotic midbodies (mMB) and mMB remnants using mouse oocytes and demonstrate that mMBs have a specialized cap structure that is orientated toward polar bodies. We show that that mMBs are translationally active, and that mMB caps are required to retain nascent proteins in eggs. We propose that this specialized mMB cap maintains genetic factors in eggs allowing for full developmental competency.
- 16 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
Open AccessAn oocyte meiotic midbody cap is required for developmental competence in mice
Embryo development depends upon maternally derived materials. Mammalian oocytes undergo extreme asymmetric cytokinesis events, producing one large egg and two small polar bodies. During cytokinesis in somatic cells, the midbody and subsequent assembly of the midbody remnant, a signaling organelle containing RNAs, transcription factors and translation machinery, is thought to influence cellular function or fate. The role of the midbody and midbody remnant in gametes, in particular, oocytes, remains unclear. Here, we examined the formation and function of meiotic midbodies (mMB) and mMB remnants using mouse oocytes and demonstrate that mMBs have a specialized cap structure that is orientated toward polar bodies. We show that that mMBs are translationally active, and that mMB caps are required to retain nascent proteins in eggs. We propose that this specialized mMB cap maintains genetic factors in eggs allowing for full developmental competency.
- Open Access
- 5 October 2023
- Published by Springer Nature in Research Square
An oocyte meiotic midbody cap is required for developmental competence in mice
Embryo development depends upon maternally derived materials. Mammalian oocytes undergo extreme asymmetric cytokinesis events, producing one large egg and two small polar bodies (PB). During cytokinesis in somatic cells, the midbody (MB) and subsequent assembly of the midbody remnant (MBR), a signaling organelle containing RNAs, transcription factors and translation machinery, is thought to influence cellular function or fate. The role of the MB and MBR in gametes, in particular, oocytes, remains unclear. Here, we examined the formation and function of meiotic MBs (mMB) and mMB remnants (mMBRs) using mouse oocytes and demonstrate that mMBs have a specialized meiotic mMB cap structure that is orientated toward PBs. We show that that mMBs are translationally active, and that mMB caps are required to retain nascent proteins in eggs. We propose that this specialized mMB cap maintains genetic factors in eggs allowing for full developmental competency.
- 5 October 2023
- Published by Springer Nature in Research Square
Open AccessAn oocyte meiotic midbody cap is required for developmental competence in mice
Embryo development depends upon maternally derived materials. Mammalian oocytes undergo extreme asymmetric cytokinesis events, producing one large egg and two small polar bodies (PB). During cytokinesis in somatic cells, the midbody (MB) and subsequent assembly of the midbody remnant (MBR), a signaling organelle containing RNAs, transcription factors and translation machinery, is thought to influence cellular function or fate. The role of the MB and MBR in gametes, in particular, oocytes, remains unclear. Here, we examined the formation and function of meiotic MBs (mMB) and mMB remnants (mMBRs) using mouse oocytes and demonstrate that mMBs have a specialized meiotic mMB cap structure that is orientated toward PBs. We show that that mMBs are translationally active, and that mMB caps are required to retain nascent proteins in eggs. We propose that this specialized mMB cap maintains genetic factors in eggs allowing for full developmental competency.
- Open Access
- 9 September 2023
- Published by Elsevier in STAR Protocols
- Vol. 4 (4) , 102562
A protocol for isolating and imaging large extracellular vesicles or midbody remnants from mammalian cell culture
- 9 September 2023
- Published by Elsevier in STAR Protocols
- Vol. 4 (4) , 102562
Open AccessA protocol for isolating and imaging large extracellular vesicles or midbody remnants from mammalian cell culture
- Open Access
- 7 August 2023
- Published by Elsevier in Developmental Cell
- Vol. 58 (19) , 1917-1932.e6
The mammalian midbody and midbody remnant are assembly sites for RNA and localized translation
- 7 August 2023
- Published by Elsevier in Developmental Cell
- Vol. 58 (19) , 1917-1932.e6
Open AccessThe mammalian midbody and midbody remnant are assembly sites for RNA and localized translation
- Open Access
- 18 July 2023
- Published by Springer Nature in Research Square
The biogenesis of large extracellular vesicles occurs in mitosis
Cells communicate with neighboring cells through shedding and uptake of extracellular vesicles (EVs). EVs are small packages of nucleic acid and protein enclosed in a lipid bilayer. Despite being broadly studied since 2010, the biogenesis of EVs remains elusive. Currently, cells in interphase are thought to shed the bulk of EVs. Given that cancer cells shed more EVs than non-cancerous cells, we hypothesized that the primary origin of large EVs may be mitosis. Here, we demonstrate that the biogenesis of large EVs occurs in mitosis. We found that the canonical EV markers, CD9, CD63, CD81, flotillin-1, and dsRNA, localize to the spindle midzone microtubules, midbody, and midbody remnant (MBR) during mitosis. These EV markers co-localized with the master regulator of cytokinesis, MKLP1, throughout mitosis, suggesting that large EV assembly and packaging occur during mitosis. Next, we showed that standard, commercial, and our newly developed EV isolation methods all isolate MBRs, evidenced by the presence of CD9 and MKLP1 double-positive vesicles. We developed two new methods of large EV isolation utilizing 1.5% PEG 6000 and PEGylated gold nanoparticles. Regardless of the isolation method, EVs are characterized using markers for transmembrane proteins called tetraspanins (CD9, CD63, and CD81), and found that ~99% of all isolated MKLP1-labeled vesicles were also CD9 positive, suggesting that large EVs are MBRs, not a separate class of EVs. Additionally, all isolation methods tested suggest that large EV have translation capacity, distinct from other EV classes. Our results demonstrate that mitotic cells give rise to the bulk of large EVs commonly researched in the field. Importantly, we show that all commercial isolation methods for EVs actually isolate MBRs, suggesting that experiments performed in the EV field are of mitotic origin. This work has broad implications for the assembly and packaging of large EVs, specifically for engineering drug therapeutics and isolation of large EVs, or MBRs, for cancer diagnosis.
- 18 July 2023
- Published by Springer Nature in Research Square
Open AccessThe biogenesis of large extracellular vesicles occurs in mitosis
Cells communicate with neighboring cells through shedding and uptake of extracellular vesicles (EVs). EVs are small packages of nucleic acid and protein enclosed in a lipid bilayer. Despite being broadly studied since 2010, the biogenesis of EVs remains elusive. Currently, cells in interphase are thought to shed the bulk of EVs. Given that cancer cells shed more EVs than non-cancerous cells, we hypothesized that the primary origin of large EVs may be mitosis. Here, we demonstrate that the biogenesis of large EVs occurs in mitosis. We found that the canonical EV markers, CD9, CD63, CD81, flotillin-1, and dsRNA, localize to the spindle midzone microtubules, midbody, and midbody remnant (MBR) during mitosis. These EV markers co-localized with the master regulator of cytokinesis, MKLP1, throughout mitosis, suggesting that large EV assembly and packaging occur during mitosis. Next, we showed that standard, commercial, and our newly developed EV isolation methods all isolate MBRs, evidenced by the presence of CD9 and MKLP1 double-positive vesicles. We developed two new methods of large EV isolation utilizing 1.5% PEG 6000 and PEGylated gold nanoparticles. Regardless of the isolation method, EVs are characterized using markers for transmembrane proteins called tetraspanins (CD9, CD63, and CD81), and found that ~99% of all isolated MKLP1-labeled vesicles were also CD9 positive, suggesting that large EVs are MBRs, not a separate class of EVs. Additionally, all isolation methods tested suggest that large EV have translation capacity, distinct from other EV classes. Our results demonstrate that mitotic cells give rise to the bulk of large EVs commonly researched in the field. Importantly, we show that all commercial isolation methods for EVs actually isolate MBRs, suggesting that experiments performed in the EV field are of mitotic origin. This work has broad implications for the assembly and packaging of large EVs, specifically for engineering drug therapeutics and isolation of large EVs, or MBRs, for cancer diagnosis.